论文部分内容阅读
目的:探究小剂量131碘联合甲巯咪唑治疗甲状腺功能亢进的临床疗效。方法:选取2012年12月至2014年1月我院收治的208例甲状腺功能亢进患者,随机分为研究组和对照组,各104例,对照组患者予常规治疗结合甲巯咪唑,研究组患者在对照组的基础上联合施用小剂量131碘,比较分析2组临床疗效及患者不良反应发生情况。结果:与对照组相比,研究组临床疗效显著提高(P<0.05),治疗期间患者不良反应发生情况显著降低(P<0.05)。结论:予甲状腺功能亢进患者小剂量131碘联合甲巯咪唑进行治疗,其临床疗效显著,值得广泛应用。
Objective: To investigate the clinical efficacy of low dose 131 iodine combined with methimazole in the treatment of hyperthyroidism. Methods: A total of 208 hyperthyroidism patients admitted to our hospital from December 2012 to January 2014 were randomly divided into study group and control group, with 104 cases in each group. Patients in control group received routine treatment combined with methimazole. Patients in study group In the control group based on the combination of low-dose 131I, comparative analysis of two groups of clinical efficacy and adverse reactions in patients. Results: Compared with the control group, the clinical efficacy of the study group was significantly increased (P <0.05), and the incidence of adverse reactions was significantly lower in the treatment group (P <0.05). Conclusion: The treatment of 131I combined with methimazole in patients with hyperthyroidism is significant, and it is worth to be widely used.